< Back
Private equity investment in the life sciences sector
Emma Danks, Colin McCall and team look at the benefits and challenges for life sciences businesses considering PE investment, and emerging trends. More 
UK increases scrutiny of tech and life sciences deals
Paulo Palmigiano looks at the signs of a greater level of scrutiny of life sciences deals by the CMA and UK government. More
How to prepare for the MHRA's new medical devices enforcement rules
Alison Dennis, Tim Strong and Justyna Ostrowska look at the impact of the Medicines and Medical Devices Bill 2020-21. More
Placing medical devices on the UK market after the end of Brexit transition
Alison Dennis discusses incoming rules and MHRA guidance for placing medical devices on the market in Great Britain and Northern Ireland. More
Targeted treatments – Part 4: patenting digital devices
Paul England looks at issues around patent protection for digital devices as part of a series of articles on targeted treatments. More
Patent pools: an easy licensing option?
Anja Lunze and Jan Phillip Rektorschek consider whether patent pools can play a key role in rapid development of a COVID-19 vaccine. More
The latest in life sciences
We look at hot topics in life sciences, from the investment and deal environment, to incoming Brexit-related rules for medical devices, targeted treatments, and patent pools as a facilitator of the longed-for COVID-19 vaccine.